Deep sequencing reveals microbiota dysbiosis of tongue coat in patients with liver carcinoma

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Lu, Haifeng ^a   Ren, Zhigang ^a,b   Li, Ang ^a   Zhang, Hua ^a   Jiang, Jianwen ^a,b   Xu, Shaoyan ^b   Luo, Qixia ^a   Zhou, Kai ^c   Sun, Xiaoli ^a   Zheng, Shusen ^a,b   Li, Lanjuan ^a  

^a University School of Medicine   (China)

^b BEIJING HOSPITAL   (China)

^c First Affiliated Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

CARCINOMA; DYSBIOSIS; FEMALE; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; LIVER; LIVER TUMOR; MALE; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PROCEDURES; TONGUE;

CARCINOMA; DYSBIOSIS; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICROBIOTA; MIDDLE AGED; RNA, RIBOSOMAL, 16S; TONGUE;

EID: 84986550480     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep33142     Document Type: Article

References (41)

1. Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359-386 (2015).
2. Chassaing, B., Etienne-Mesmin, L. & Gewirtz, A. T. Microbiota-liver axis in hepatic disease. Hepatology 59, 328-339 (2014).
3. Chen, Y. et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54, 562-572 (2011).
4. Qin, N. et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 513, 59-64 (2014).
5. Bajaj, J. S. et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol 60, 940-947 (2014).
6. Dapito, D. H. et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21, 504-516 (2012).
7. Schnabl, B. & Brenner, D. A. Interactions between the intestinal microbiome and liver diseases. Gastroenterology 146, 1513-1524 (2014).
8. Wade, W. G. The oral microbiome in health and disease. Pharmacol Res 69, 137-143 (2013).
9. Zarco, M. F., Vess, T. J. & Ginsburg, G. S. The oral microbiome in health and disease and the potential impact on personalized dental medicine. Oral Dis 18, 109-120 (2012).
10. Bajaj, J. S. et al. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy. Hepatology 62, 1260-1271 (2015).
11. Aas, J. A., Paster, B. J., Stokes, L. N., Olsen, I. & Dewhirst, F. E. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 43, 5721-5732 (2005).
12. Chen, H. & Jiang, W. Application of high-throughput sequencing in understanding human oral microbiome related with health and disease. Front Microbiol 5, 508 (2014).
13. Farrell, J. J. et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut 61, 582-588 (2012).
14. Lawrence, H. P. Salivary markers of systemic disease: noninvasive diagnosis of disease and monitoring of general health. J Can Dent Assoc 68, 170-174 (2002).
15. Anastasi, J. K., Chang, M., Quinn, J. & Capili, B. Tongue Inspection in TCM: Observations in a Study Sample of Patients Living with HIV. Med Acupunct 26, 15-22 (2014).
16. Langille, M. G. et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 31, 814-821 (2013).
17. Umemura, K. & Wada, K. Roles of oral bacteria in cardiovascular diseases-from molecular mechanisms to clinical cases: preface. J Pharmacol Sci 113, 101-102 (2010).
18. Zhang, X. et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med 21, 895-905 (2015).
19. Filkins, L. M. et al. Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability. J Bacteriol 194, 4709-4717 (2012).
20. Bik, E. M. et al. Bacterial diversity in the oral cavity of 10 healthy individuals. ISME J 4, 962-974 (2010).
21. Ling, Z. et al. Pyrosequencing analysis of the human microbiota of healthy Chinese undergraduates. BMC Genomics 14, 390 (2013).
22. Liu, B. et al. Deep sequencing of the oral microbiome reveals signatures of periodontal disease. Plos One 7, e37919 (2012).
23. Duran-Pinedo, A. E. & Frias-Lopez, J. Beyond microbial community composition: functional activities of the oral microbiome in health and disease. Microbes Infect 17, 505-516 (2015).
24. Jagtap, P. et al. Deep metaproteomic analysis of human salivary supernatant. Proteomics 12, 992-1001 (2012).
25. Pushalkar, S. et al. Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma. BMC Microbiol 12, 144 (2012).
26. Zaura, E., Keijser, B. J., Huse, S. M. & Crielaard, W. Defining the healthy "core microbiome" of oral microbial communities. BMC Microbiol 9, 259 (2009).
27. Fox, J. G. et al. Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut 59, 88-97 (2010).
28. Viaud, S. et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342, 971-976 (2013).
29. Darnaud, M., Faivre, J. & Moniaux, N. Targeting gut flora to prevent progression of hepatocellular carcinoma. J Hepatol 58, 385-387 (2013).
30. Llovet, J. M., Bru, C. & Bruix, J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19, 329-338 (1999).
31. Bruix, J. & Llovet, J. M. Major achievements in hepatocellular carcinoma. Lancet 373, 614-616 (2009).
32. Wittekind, C. [Pitfalls in the classification of liver tumors]. Pathologe 27, 289-293 (2006).
33. Winkel, E. G., Roldan, S., Van Winkelhoff, A. J., Herrera, D. & Sanz, M. Clinical effects of a new mouthrinse containing chlorhexidine, cetylpyridinium chloride and zinc-lactate on oral halitosis. A dual-center, double-blind placebo-controlled study. J Clin Periodontol 30, 300-306 (2003).
34. Cherel, F. et al. Rate of reformation of tongue coatings in young adults.Int J Dent Hyg 6, 371-375 (2008).
35. Ren, Z. et al. Intestinal microbial variation may predict early acute rejection after liver transplantation in rats. Transplantation 98, 844-852 (2014).
36. Ren, Z. et al. Liver ischemic preconditioning (IPC) improves intestinal microbiota following liver transplantation in rats through 16s rDNA-based analysis of microbial structure shift. Plos One 8, e75950 (2013).
37. Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460-2461 (2010).
38. Zhang, Y., Wang, X., Hu, M. & Li, P. Effect of hydraulic retention time (HRT) on the biodegradation of trichloroethylene wastewater and anaerobic bacterial community in the UASB reactor. Appl Microbiol Biotechnol 99, 1977-1987 (2015).
39. Cole, J. R. et al. The ribosomal database project (RDP-II): introducing myRDP space and quality controlled public data. Nucleic Acids Res 35, D169-172 (2007).
40. Javurek, A. B. et al. Discovery of a Novel Seminal Fluid Microbiome and Influence of Estrogen Receptor Alpha Genetic Status. Sci Rep 6, 23027 (2016).
41. Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol 12, R60 (2011).